Clinical Trials Sponsored by French Lung Cancer Group

Total 106 results

Centre Hospitalier Annecy Genevois
French Lung Cancer Group

Active, not recruiting

Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS) (DENIVOS)

Carcinoma, Non-Small-Cell Lung | Bone Metastases

France
Spanish Lung Cancer Group

Completed

Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Active, not recruiting

Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

Non-small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone (GOAL)

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Terminated

Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC (Phalcis)

Carcinoma, Non Small Cell Lung

Spain
Spanish Lung Cancer Group

Terminated

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Terminated

Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma (BREC)

Non Small Cell Lung Cancer | BRCA1 Mutation

Spain
Spanish Lung Cancer Group

Completed

Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC (NORA)

Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) (GECP-SCAT)

Non-small-cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab (ANGIOMET)

Nonsquamous Nonsmall Cell Neoplasm of Lung

Spain
Spanish Lung Cancer Group

Recruiting

Thoracic Tumours Register (RTT)

Thoracic Tumors

Spain
Lung Cancer Group Cologne

Terminated

FGFR Inhibitor in FGFR Dysregulated Cancer (FIND)

NSCLC | Lung Cancer | NSCLC Stage IV | Squamous Cell Lung Cancer | Pulmonary Neoplasm

Germany
Spanish Lung Cancer Group

Completed

Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC (Replay)

Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis (ATEZO-BRAIN)

Non-small Cell Lung Cancer Stage IV

Spain
Spanish Lung Cancer Group

Completed

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) (GRAVID)

Covid-19 | Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer (NATCH)

Non-Small-Cell Lung Cancer
Spanish Lung Cancer Group

Completed

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR (EURTAC)

Non-Small Cell Lung Cancer

Spain, France, Italy
Spanish Lung Cancer Group

Completed

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma (SLAT)

Non-small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Durvalumab in Solid Tumors

Cancer | HIV

Spain
Spanish Lung Cancer Group

Completed

T790M Mutation Testing in Blood by Different Methodologies

NSCLC Stage IV

Spain
Spanish Lung Cancer Group

Completed

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient (NIVEX)

Non Small Cell Lung Cancer

Spain
Lung Cancer Group Cologne

Unknown

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (ERLOPET)

Carcinoma, Non-Small-Cell Lung

Germany
Swedish Lung Cancer Study Group

Recruiting

Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC (MARS)

Quality of Life | Non Small Cell Lung Cancer | Radiotherapy | Stage IV Non-small Cell Lung Cancer

Sweden
Danish Oncological Lung Cancer Group

Terminated

Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

Small Cell Lung Cancer | Extensive Disease | First-Line

Denmark
Spanish Lung Cancer Group
Aventis Pharmaceuticals

Completed

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer (GECP0008)

Non Small-cell Lung Cancer
The Norwegian Lung Cancer Study Group

Completed

Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

Norway
Rigshospitalet, Denmark
Danish Lung Cancer Group; Danish Comprehensive Cancer Center

Active, not recruiting

Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy (SUPE_R)

Carcinoma, Non-Small-Cell Lung

Denmark
London Lung Cancer Group

Completed

Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer

Lung Cancer

United Kingdom
Lung Cancer Group Cologne
Bristol-Myers Squibb

Completed

BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer

Carcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell Lung

Germany
Finnish Lung Cancer Group
Roche Pharma AG

Completed

Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC

Non-small Cell Lung Cancer

Finland
Trans Tasman Radiation Oncology Group
Australasian Lung Cancer Trials Group

Completed

A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II) (SAFRON II)

Cancer | Metastases to the Lung

Australia
University Hospital, Lille
National Cancer Institute, France; French Eso-Gastric Tumors Working Group

Recruiting

The French EsoGastricTumours Data Base (FREGAT)

Esophageal Disease

France
Lund University
Swedish Breast Cancer Group

Completed

No Axillary Surgery for Early Breast Cancer.

Breast Cancer Invasive
ETOP IBCSG Partners Foundation
Spanish Lung Cancer Group

Completed

BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC) (BELIEF)

Lung Cancer

Spain, Ireland, United Kingdom, Switzerland, France, Germany, Greece, Italy
University of Cologne
Pfizer; Spanish Lung Cancer Group

Completed

EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer (EUCROSS)

Adenocarcinoma | NSCLC | Lung Cancer

Germany, Spain, Switzerland
Spanish Lung Cancer Group
Merck Sharp & Dohme LLC

Terminated

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Non-small Cell Lung Cancer

Spain
Lund University Hospital
Danish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaborators

Recruiting

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Breast Cancer | Triple Negative Breast Neoplasms

Denmark, Sweden
University of Sydney
AstraZeneca; Australasian Lung Cancer Trials Group

Active, not recruiting

Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease. (ILLUMINATE)

EGFR Mutant Advanced Non Small Cell Lung Cancer

Taiwan, Australia
University Hospital, Linkoeping
Pfizer; Swedish Lung Cancer Study Group

Unknown

Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy (CYCLUS)

Non-Small Cell Lung Cancer

Sweden
Ass. Prof. Jan Nyman

Recruiting

Study on Proton Radiotherapy of Thymic Malignancies (PROTHYM)

Thymus Neoplasms | Cardiotoxicity | Pulmonary Toxicity

Sweden
Ass. Prof. Jan Nyman

Terminated

Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy (PLANET)

Non Small Cell Lung Cancer | Locally Advanced Disease

Sweden
Rigshospitalet, Denmark
Aarhus University Hospital; Danish Lung Cancer Group

Completed

Chronic Pain After Thoracotomy, an Incidence Study

Chronic Pain | Thoracotomy

Denmark
Regional Hospital West Jutland
Danish Cancer Society; Danish Lung Cancer Group

Completed

Intensified Follow-up of Lung Cancer Using Weekly Questionnaires Via the Internet (ProWide)

Lung Cancer

Denmark
Regional Hospital West Jutland
Danish Cancer Society; Danish Lung Cancer Group

Completed

Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients

Lung Cancer Stage IV

Denmark
Lund University Hospital
South Sweden Breast Cancer Group

Recruiting

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer (ABC-SE)

Breast Cancer

Sweden
French Africa Pediatric Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma (GFAOPLH2019)

Staging | Therapeutic Recommendations

France
French Africa Pediatric Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP (LALGFA2019)

Childhood ALL

Côte D'Ivoire, Senegal, Guinea
French Africa Pediatric Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa (RFAOP)

Pediatric Cancer

Burkina Faso, Cameroon, Congo, The Democratic Republic of the, Côte D'Ivoire, France, Gabon, Madagascar, Mali, Mauritania, Niger, Senegal, Togo
Centre Francois Baclesse
ARCAGY/ GINECO GROUP; French Cancer Research Hospital Program

Completed

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer (MONAVI-1)

Platinum-resistant or Refractory Ovarian Cancer

France

Clinical Trials Sponsored by French Lung Cancer Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations